Clinical use of androgens.
The principal clinical use of androgens is the treatment of testosterone deficiency in a male who has primary hypogonadism or who has secondary hypogonadism but is not interested in becoming fertile within the subsequent year. For the treatment of testosterone deficiency in the adult male, one of the two long-acting esters of testosterone, testosterone enanthate or testosterone cypionate, should be administered by intramuscular injection, 200 mg every two weeks or 300 mg every three weeks. The alkylated testosterone derivatives, which can be administered orally, are probably too weak as androgens to be used for the treatment of adult male hypogonadism, but they may have value in situations where full androgenization is not desired, such as adjuvant treatment of breast carcinoma.
D000728:Androgens / Q000494:pharmacology / Q000502:physiology / Q000627:therapeutic use*; D055598:Chemical Phenomena; D002621:Chemistry; D006801:Humans; D007006:Hypogonadism / Q000097:blood / Q000188:drug therapy*; D007986:Luteinizing Hormone / Q000097:blood; D008297:Male; D013739:Testosterone / Q000031:analogs & derivatives / Q000097:blood / Q000494:pharmacology / Q000502:physiology / Q000627:therapeutic use
D000728:Androgens; D013739:Testosterone; D007986:Luteinizing Hormone